Role of Toll-Like Receptors in Innate Immunity of the Intestine

Elke Cario; Daniel K. Podolsky

doi:10.1128/9781555817848.ch5

Chapter 5 : Role of Toll-Like Receptors in Innate Immunity of the Intestine

Authors: Elke Cario¹, Daniel K. Podolsky²

VIEW AFFILIATIONS HIDE AFFILIATIONS

Affiliations: 1: Division of Gastroenterology and Hepatology, University of Essen, Essen, Germany; 2: Gastrointestinal Unit, Center for the Study of Inflammatory Bowel Disease, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114

Content Type: Monograph

Publication Year: 2003

Category: Clinical Microbiology

Book DOI: 10.1128/9781555817848

Chapter DOI: 10.1128/9781555817848.ch5

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:

Role of Toll-Like Receptors in Innate Immunity of the Intestine, Page 1 of 2

< Previous page | Next page > /docserver/preview/fulltext/10.1128/9781555817848/9781555812614_Chap05-1.gif /docserver/preview/fulltext/10.1128/9781555817848/9781555812614_Chap05-2.gif

Abstract:

The pre-epithelial mucous layer at the apical epithelial surface-consisting of mucin glycoproteins, trefoil peptides, and, in the small intestine, defensins-significantly contributes to efficient protection of the underlying host. Toll-like receptors (TLR) are found expressed by many cell types throughout the whole gastrointestinal tract in vitro and in vivo, e.g., several intestinal epithelial cells (IEC) lines of the small intestine and colon, gastric pit cells, fetal intestinal cells, intestinal macrophages of the lamina propria, and intestinal myofibroblasts. Mammalian TLR may enable IEC to participate in innate immunity to microbial pathogens in at least four ways: (i) recognition of molecular patterns present on commensals and pathogens; (ii) expression at the interface with the “environment” of the gastrointestinal lumen; (iii) induction of secretion of pro-or anti-inflammatory cytokines and chemokines that link to the adaptive immune system; and (iv) induction of antimicrobial effector pathways. The chapter talks about alteration of TLR expression in human inflammatory bowel disease (IBD), and TLR dysregulation in infectious diseases. Future research will identify further TLR ligands, specify interconnective signaling cascades activated by TLR, and clarify the potential role of intestinal epithelial TLR in the pathogenesis of IBD and other aberrant inflammatory processes in the gastrointestinal tract. Identifying the physiological mechanisms through which intestinal TLR and other pattern-recognition receptors (PRR) modulate host defense in the gastrointestinal tract could lead to new therapeutic approaches to combat microbial associated gastrointestinal disorders, such as infectious diseases and perhaps IBD.

Citation: Cario E, Podolsky D. 2003. Role of Toll-Like Receptors in Innate Immunity of the Intestine, p 79-94. In Hecht G (ed), Microbial Pathogenesis and the Intestinal Epithelial Cell. ASM Press, Washington, DC. doi: 10.1128/9781555817848.ch5

Highlighted Text: Show | Hide

Full text loading...

Figures

Role of Toll-Like Receptors in Innate Immunity of the Intestine

[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555817848.chap5-1,webId=/content/author/10.1128/9781555817848.chap5-1,properties={foaf_givenname=Elke, foaf_name=Elke Cario, foaf_surname=Cario, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/10.1128/9781555817848.chap5-aff1]]}], com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555817848.chap5-2,webId=/content/author/10.1128/9781555817848.chap5-2,properties={foaf_givenname=Daniel K., foaf_name=Daniel K. Podolsky, foaf_surname=Podolsky, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/10.1128/9781555817848.chap5-aff2]]}]]

/content/10.1128/9781555817848.chap5.fig5-1

FIGURE 1.

Different PAMPs activate different TLRs. TLRs recognize specifically a restricted number of PAMP or CAMP. TLR2 interacts with TLR1 and TLR6 in recognition of a variety of ligands, mainly gram-positive bacterial cell wall components. Aided by at least three other molecules, including CD14, LPS-binding-protein (LBP), and MD-2, TLR4 mainly detects LPS. Double-stranded RNA is recognized by TLR3, and TLR5 binds flagellin. TLR9 is a receptor for abundant bacterial CpG DNA. The ligands for TLR7, TLR8, and TLR10 remain to be determined.

10.1128/9781555817848/fig5-1_thmb.gif

10.1128/9781555817848/fig5-1.gif

FIGURE 1.

/content/10.1128/9781555817848.chap5.fig5-2

FIGURE 2.

Signaling pathways of TLRx—current concept. TLR signal through several signaling components, including the adapter protein MyD88, Toll-interacting protein (Tollip), IL-1R-associated kinase (IRAK), and TNF receptor-associated factor 6 (TRAF-6), leading to liberation of the transcription factor NF-ĸB and activation of MKK and the JNK-p38 pathways. All these events lead downstream to the transcription of various cytokine/chemokine genes. TLR4 also signals through an MyD88-independent pathway via another adapter, recently identified as TIRAP (or Mal). The interactions among TLR versus MyD88, TIRAP, and Tollip are complex and remain unresolved. The protein kinase PKR is possibly positioned between TIRAP and TRAF-6. Rho GTPase Rac-1 and Akt have also been shown to mediate TLR2-dependent activation. The roles of other PRR, such as TREM or Nods, possibly interacting with TLR signaling proteins and thus regulating innate immune responses to bacterial ligands, remain to be defined.

10.1128/9781555817848/fig5-2_thmb.gif

10.1128/9781555817848/fig5-2.gif

FIGURE 2.

References

/content/book/10.1128/9781555817848.chap5

1. Abreu, M. T.,, P. Vora,, E. Faure,, L. S. Thomas,, E. T. Arnold,, and M. Arditi. 2001. Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide. J. Immunol. 167: 1609– 1616.

2. Alexopoulou, L.,, A. C. Holt,, R. Medzhitov,, and R. A. Flavell. 2001. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413: 732– 738.

3. Aliprantis, A. O.,, R. B. Yang,, D. S. Weiss,, P. Godowski,, and A. Zychlinsky. 2000. The apoptotic signaling pathway activated by Toll-like receptor-2. EMBO J. 19: 3325– 3336.

4. Amar, S.,, K. Oyaisu,, L. Li,, and T. Van Dyke. 2001. Moesin: a potential LPS receptor on human monocytes. J. Endotoxin Res. 7: 281– 286.

5. Anderson, K. V. 2000. Toll signaling pathways in the innate immune response. Curr. Opin. Immunol. 12: 13– 19.

6. Arbibe, L.,, J. P. Mira,, N. Teusch,, L. Kline,, M. Guha,, N. Mackman,, P. J. Godowski,, R. J. Ulevitch,, and U. G. Knaus. 2000. Tolllike receptor 2-mediated NF-kappa B activation requires a Rac1-dependent pathway. Nat. Immunol. 1: 533– 540.

7. Beatty, W. L.,, S. Meresse,, P. Gounon,, J. Davoust,, J. Mounier,, P. J. Sansonetti,, and J. P. Gorvel. 1999. Trafficking of Shigella lipopolysaccharide in polarized intestinal epithelial cells. J. Cell Biol. 145: 689– 698.

8. Beatty, W. L.,, and P. J. Sansonetti. 1997. Role of lipopolysaccharide in signaling to subepithelial polymorphonuclear leukocytes. Infect. Immun. 65: 4395– 4404.

9. Beutler, B. 2001. Sepsis begins at the interface of pathogen and host. Biochem. Soc. Trans. 29: 853– 859.

10. Beutler, B.,, and R. J. Ulevitch. 2001. Genetic analysis of host responses in sepsis. Curr. Infect. Dis. Rep. 3: 419.

11. Bogunovic, M.,, S. Reka,, K. N. Evans,, L. F. Mayer,, K. Sperber,, and S. E. Plevy. 2000. Functional Toll-like receptors (TLR) are expressed on intestinal epithelial cells (IEC) Gastroenterology 118: A804.

12. Bouchon, A.,, J. Dietrich,, and M. Colonna. 2000. Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J. Immunol. 164: 4991– 4995.

13. Bouchon, A.,, F. Facchetti,, M. A. Weigand,, and M. Colonna. 2001. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 410: 1103– 1107.

14. Bulut, Y.,, E. Faure,, L. Thomas,, O. Equils,, and M. Arditi. 2001. Cooperation of Toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: role of Toll-interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signaling. J. Immunol. 167: 987– 994.

15. Burns, K.,, J. Clatworthy,, L. Martin,, F. Martinon,, C. Plumpton,, B. Maschera,, A. Lewis,, K. Ray,, J. Tschopp,, and F. Volpe. 2000. Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor. Nat. Cell Biol. 2: 346– 351.

16. Campbell, N.,, X. Y. Yio,, L. P. So,, Y. Li,, and L. Mayer. 1999. The intestinal epithelial cell: processing and presentation of antigen to the mucosal immune system. Immunol. Rev. 172: 315– 324.

17. Campbell, N. A.,, H. S. Kim,, R. S. Blumberg,, and L. Mayer. 1999. The nonclassical class I molecule CD1d associates with the novel CD8 ligand gp180 on intestinal epithelial cells. J. Biol. Chem. 274: 26259– 26265.

18. Cario, E.,, D. Brown,, M. McKee,, K. Lynch-Devaney,, G. Gerken,, and D. K. Podolsky. 2002. Commensal-associated molecular pattern molecules induce selective toll-like receptor-trafficking from apical membrane to cytoplasmic compartments in polarized intestinal epithelium. Am. J. Pathol. 160: 165– 173.

19. Cario, E.,, and D. K. Podolsky. 2000. Differential alteration in intestinal epithelial cell expression of Toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect. Immun. 68: 7010– 7017.

20. Cario, E.,, I. M. Rosenberg,, S. L. Brandwein,, P. L. Beck,, H. C. Reinecker,, and D. K. Podolsky. 2000. Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors. J. Immunol. 164: 966– 972.

21. Charpentier, J.,, and J. P. Mira. 2001. Role of host response during severe bacterial infection. Arch. Pediatr. 8(Suppl. 4): 689S– 696S.

22. Chen, T. Y.,, M. G. Lei,, T. Suzuki,, and D. C. Morrison. 1992. Lipopolysaccharide receptors and signal transduction pathways in mononuclear phagocytes. Curr. Top. Microbiol. Immunol. 181: 169– 188.

23. Chow, J. C.,, D. W. Young,, D. T. Golenbock,, W. J. Christ,, and F. Gusovsky. 1999. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J. Biol. Chem. 274: 10689– 10692.

24. Chuang, T. H.,, and R. J. Ulevitch. 2000. Cloning and characterization of a sub-family of human Toll-like receptors: hTLR7, hTLR8 and hTLR9. Eur. Cytokine Netw. 11: 372– 378.

25. Chuang, T. H.,, and R. J. Ulevitch. 2001. Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cells. Biochim. Biophys. Acta 1518: 157– 161.

26. Chung, C. S.,, G. Y. Song,, L. L. Moldawer,, I. H. Chaudry,, and A. Ayala. 2000. Neither Fas ligand nor endotoxin is responsible for inducible peritoneal phagocyte apoptosis during sepsis/peritonitis. J. Surg. Res. 91: 147– 153.

27. da Silva Correia, J.,, K. Soldau,, U. Christen,, P. S. Tobias,, and R. J. Ulevitch. 2001. Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex. Transfer from CD14 to TLR4 and MD-2. J. Biol. Chem. 276: 21129– 21135.

28. Dalpke, A. H.,, S. Opper,, S. Zimmermann,, and K. Heeg. 2001. Suppressors of cytokine signaling (SOCS)-1 and SOCS-3 are induced by CpG-DNA and modulate cytokine responses in APCs. J. Immunol. 166: 7082– 7089.

29. Edwards, E. W.,, M. Bogunovic,, J. Yager,, and S. E. Plevy. 2001. Toll-like receptor expression and function in intestinal epithelial cells: an epithelial cell type co-expressing TLR1 and TLR2. FASEB J. 2001: abstract.

30. Equils, O.,, E. Faure,, L. Thomas,, Y. Bulut,, S. Trushin,, and M. Arditi. 2001. Bacterial lipopolysaccharide activates HIV long terminal repeat through Toll-like receptor 4. J. Immunol. 166: 2342– 2347.

31. Faure, E.,, O. Equils,, P. A. Sieling,, L. Thomas,, F. X. Zhang,, C. J. Kirschning,, N. Polentarutti,, M. Muzio,, and M. Arditi. 2000. Bacterial lipopolysaccharide activates NF-kappaB through Toll-like receptor 4 (TLR-4) in cultured human dermal endothelial cells. Differential expression of TLR-4 and TLR-2 in endothelial cells. J. Biol. Chem. 275: 11058– 11063.

32. Fitzgerald, K. A.,, E. M. Palsson-McDermott,, A. G. Bowie,, C. A. Jefferies,, A. S. Mansell,, G. Brady,, E. Brint,, A. Dunne,, P. Gray,, M. T. Harte,, D. McMurray,, D. E. Smith,, J. E. Sims,, T. A. Bird,, and L. A. O’Neill. 2001. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature 413: 78– 83.

33. Funda, D. P.,, L. Tuckova,, M. A. Farre,, T. Iwase,, I. Moro,, and H. Tlaskalova-Hogenova. 2001. CD14 is expressed and released as soluble CD14 by human intestinal epithelial cells in vitro: lipopolysaccharide activation of epithelial cells revisited. Infect. Immun. 69: 3772– 3781.

34. Fusunyan, R. D.,, N. N. Nanthakumar,, M. E. Baldeon,, and W. A. Walker. 2001. Evidence for an innate immune response in the immature human intestine: Toll-like receptors on fetal enterocytes. Pediatr. Res. 49: 589– 593.

35. Gewirtz, A. T.,, T. A. Navas,, S. Lyons,, P. J. Godowski,, and J. L. Madara. 2001. Cutting edge: bacterial flagellin activates basolaterally expressed tlr5 to induce epithelial proinflammatory gene expression. J. Immunol. 167: 1882– 1885.

36. Hacker, H.,, R. M. Vabulas,, O. Takeuchi,, K. Hoshino,, S. Akira,, and H. Wagner. 2000. Immune cell activation by bacterial CpG-DNA through myeloid differentiation marker 88 and tumor necrosis factor receptor-associated factor (TRAF)6. J. Exp. Med. 192: 595– 600.

37. Hajjar, A. M.,, D. S. O’Mahony,, A. Ozinsky,, D. M. Underhill,, A. Aderem,, S. J. Klebanoff,, and C. B. Wilson. 2001. Cutting edge: functional interactions between Toll-like receptor (TLR) 2 and TLR1 or TLR6 in response to phenol-soluble modulin. J. Immunol. 166: 15– 19.

38. Hausmann, M.,, T. Spoettl,, J. Schoelmerich,, W. Falk,, T. Andus,, and G. Rogler. 2000. Induction of Toll-like Receptor 2 in human intestinal myofibroblasts by interferon gamma. Gastroenterology 118: A791.

39. Hayashi, F.,, K. D. Smith,, A. Ozinsky,, T. R. Hawn,, E. C. Yi,, D. R. Goodlett,, J. K. Eng,, S. Akira,, D. M. Underhill,, and A. Aderem. 2001. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410: 1099– 1103.

40. Haynes, L. M.,, D. D. Moore,, E. A. Kurt-Jones,, R. W. Finberg,, L. J. Anderson,, and R. A. Tripp. 2001. Involvement of Toll-like receptor 4 in innate immunity to respiratory syncytial virus. J. Virol. 75: 10730– 10737.

41. Hecht, G. 1999. Innate mechanisms of epithelial host defense: spotlight on intestine. Am. J. Physiol. 277: C351– C358.

42. Heine, H.,, C. J. Kirschning,, E. Lien,, B. G. Monks,, M. Rothe,, and D. T. Golenbock. 1999. Cutting edge: cells that carry A null allele for Toll-like receptor 2 are capable of responding to endotoxin. J. Immunol. 162: 6971– 6975.

43. Hemmi, H.,, O. Takeuchi,, T. Kawai,, T. Kaisho,, S. Sato,, H. Sanjo,, M. Matsumoto,, K. Hoshino,, H. Wagner,, K. Takeda,, and S. Akira. 2000. A Toll-like receptor recognizes bacterial DNA. Nature 408: 740– 745.

44. Hertz, C. J.,, S. M. Kiertscher,, P. J. Godowski,, D. A. Bouis,, M. V. Norgard,, M. D. Roth,, and R. L. Modlin. 2001. Microbial lipopeptides stimulate dendritic cell maturation via Toll-like receptor 2. J. Immunol. 166: 2444– 2450.

45. Hirschfeld, M.,, Y. Ma,, J. H. Weis,, S. N. Vogel,, and J. J. Weis. 2000. Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine Toll-like receptor 2. J. Immunol. 165: 618– 622.

46. Horng, T.,, G. M. Barton,, and R. Medzhitov. 2001. TIRAP: an adapter molecule in the Toll signaling pathway. Nat. Immunol. 2: 835– 841.

47. Hugot, J. P.,, M. Chamalliard,, H. Zouali,, S. Lesage,, J. P. Cézard,, J. Belaiche,, S. Almer,, C. Tysk,, C. A. O’Morain,, M. Gassull,, V. Binder,, Y. Finkel,, A. Cortot,, R. Modigliani,, P. Laurent-Preig,, C. Gower-Rousseau,, J. Macry,, J. F. Colomvel,, M. Sahbatou,, and G. Thomas. 2001. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature 411: 599– 603.

48. Imler, J. L.,, and J. A. Hoffmann. 2000. Signalling mechanisms in the antimicrobial host de fense of Drosophila. Curr. Opin. Microbiol. 3: 16– 22.

49. Inohara, N.,, T. Koseki,, J. Lin,, L. del Peso,, P. C. Lucas,, F. F. Chen,, Y. Ogura,, and G. Nunez. 2000. An induced proximity model for NF-kappa B activation in the Nod1/RICK and RIP signaling pathways. J. Biol. Chem. 275: 27823– 27831.

50. Inohara, N.,, Y. Ogura,, F. F. Chen,, A. Muto,, and G. Nunez. 2001. Human nod1 confers responsiveness to bacterial lipopolysaccharides. J. Biol. Chem. 276: 2551– 2554.

51. Janeway, C. A. 1992. The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol. Today 13: 11.

52. Jung, H. C.,, L. Eckmann,, S. K. Yang,, A. Panja,, J. Fierer,, E. Morzycka-Wroblewska,, and M. F. Kagnoff. 1995. A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J. Clin. Invest. 95: 55– 65.

53. Kadowaki, N.,, S. Ho,, S. Antonenko,, R. W. Malefyt,, R. A. Kastelein,, F. Bazan,, and Y. J. Liu. 2001. Subsets of human dendritic cell precursors express different Toll-like receptors and respond to different microbial antigens. J. Exp. Med. 194: 863– 869.

54. Kagnoff, M. F.,, and L. Eckmann. 1997. Epithelial cells as sensors for microbial infection. J. Clin. Invest. 100: 6– 10.

55. Kaisho, T.,, and S. Akira. 2001. Dendritic-cell function in Toll-like receptor-and MyD88-knockout mice. Trends Immunol. 22: 78– 83.

56. Kaisho, T.,, O. Takeuchi,, T. Kawai,, K. Hoshino,, and S. Akira. 2001. Endotoxin-induced maturation of myd88-deficient dendritic cells. J. Immunol. 166: 5688– 5694.

57. Kang, T. J.,, and G. T. Chae. 2001. Detection of Toll-like receptor 2 (TLR2) mutation in the lepromatous leprosy patients. FEMS Immunol. Med. Microbiol. 31: 53– 58.

58. Kawahara, T.,, Y. Kuwano,, S. Teshima-Kondo,, T. Kawai,, T. Nikawa,, K. Kishi,, and K. Rokutan. 2001. Toll-like receptor 4 regulates gastric pit cell responses to Helicobacter pylori infection. J. Med. Invest. 48: 190– 197.

59. Kawahara, T.,, Y. Kuwano,, S. Teshima-Kondo,, T. Sugiyama,, T. Kawai,, T. Nikawa,, K. Kishi,, and K. Rokutan. 2001. Helicobacter pylori lipopolysaccharide from type I, but not type II strains, stimulates apoptosis of cultured gastric mucosal cells. J. Med. Invest. 48: 167– 174.

60. Kawai, T.,, O. Adachi,, T. Ogawa,, K. Takeda,, and S. Akira. 1999. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11: 115– 122.

61. Kawai, T.,, O. Takeuchi,, T. Fujita,, J. Inoue Ji,, P. F. Muhlradt,, S. Sato,, K. Hoshino,, and S. Akira. 2001. Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J. Immunol. 167: 5887– 5894.

62. Kawasaki, K.,, K. Gomi,, and M. Nishijima. 2001. Cutting edge: gln(22) of mouse MD-2 is essential for species-specific lipopolysaccharide mimetic action of taxol. J. Immunol. 166: 11– 14.

63. Kopp, E.,, R. Medzhitov,, J. Carothers,, C. Xiao,, I. Douglas,, C. A. Janeway,, and S. Ghosh. 1999. ECSIT is an evolutionarily conserved intermediate in the Toll/IL-1 signal transduction pathway. Genes Dev. 13: 2059– 2071.

64. Krutzik, S. R.,, P. A. Sieling,, and R. L. Modlin. 2001. The role of Toll-like receptors in host defense against microbial infection. Curr. Opin. Immunol. 13: 104– 108.

65. Kurt-Jones, E. A.,, L. Popova,, L. Kwinn,, L. M. Haynes,, L. P. Jones,, R. A. Tripp,, E. E. Walsh,, M. W. Freeman,, D. T. Golenbock,, L. J. Anderson,, and R. W. Finberg. 2000. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat. Immunol. 1: 398– 401.

66. Levashina, E. A.,, E. Langley,, C. Green,, D. Gubb,, M. Ashburner,, J. A. Hoffmann,, and J. M. Reichhart. 1999. Constitutive activation of Toll-mediated antifungal defense in serpindeficient Drosophila. Science 285: 1917– 1919.

67. Lorenz, E.,, M. Jones,, C. Wohlford-Lenane,, N. Meyer,, K. L. Frees,, N. C. Arbour,, and D. A. Schwartz. 2001. Genes other than TLR4 are involved in the response to inhaled LPS. Am. J. Physiol. Lung Cell Mol. Physiol. 281: L1106– L1114.

68. MacDonald, T. T.,, and S. Pettersson. 2000. Bacterial regulation of intestinal immune responses. Inflamm. Bowel Dis. 6: 116– 122.

69. Matsuguchi, T.,, K. Takagi,, T. Musikacharoen,, and Y. Yoshikai. 2000. Gene expressions of lipopolysaccharide receptors, Toll-like receptors 2 and 4, are differently regulated in mouse T lymphocytes. Blood 95: 1378– 1385.

70. Matsumura, T.,, A. Ito,, T. Takii,, H. Hayashi,, and K. Onozaki. 2000. Endotoxin and cytokine regulation of Toll-like receptor (TLR) 2 and TLR4 gene expression in murine liver and hepatocytes. J. Interferon Cytokine Res. 20: 915– 921.

71. Mayer, L. 2000. Mucosal immunity and gastrointestinal antigen processing. J. Pediatr. Gastroenterol. Nutr. 30: S4– S12.

72. Mayer, L.,, D. Eisenhardt,, P. Salomon,, W. Bauer,, R. Plous,, and L. Piccinini. 1991. Ex pression of class II molecules on intestinal epithelial cells in humans: differences between normal and inflammatory bowel disease. Gastroenterology 100: 3.

73. Means, T. K.,, D. T. Golenbock,, and M. J. Fenton. 2000. Structure and function of Toll-like receptor proteins. Life Sci. 68: 241– 258.

74. Medvedev, A. E.,, K. M. Kopydlowski,, and S. N. Vogel. 2000. Inhibition of lipopolysaccharide-induced signal transduction in endotoxin-tolerized mouse macrophages: dysregulation of cytokine, chemokine, and Toll-like receptor 2 and 4 gene expression. J. Immunol. 164: 5564– 5574.

75. Medzhitov, R.,, and C. A. Janeway. 2000. Innate immunity. N. Engl. J. Med. 343: 338– 344.

76. Medzhitov, R.,, P. Preston-Hurlburt,, and C. A. Janeway. 1997. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388: 394– 397.

77. Meijssen, M. A.,, S. L. Brandwein,, H. C. Reinecker,, A. K. Bhan,, and D. K. Podolsky. 1998. Alteration of gene expression by intestinal epithelial cells precedes colitis in interleukin-2-deficient mice. Am. J. Physiol. 274: G472– G479.

78. Miettinen, M.,, T. Sareneva,, I. Julkunen,, and S. Matikainen. 2001. IFNs activate Toll-like receptor gene expression in viral infections. Genes Immun. 2: 349– 355.

79. Muzio, M.,, D. Bosisio,, N. Polentarutti,, G. D’Amico,, A. Stoppacciaro,, R. Mancinelli,, C. van’t Veer,, G. Penton-Rol,, L. P. Ruco,, P. Allavena,, and A. Mantovani. 2000. Differential expression and regulation of Toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells. J. Immunol. 164: 5998– 6004.

80. Muzio, M.,, N. Polentarutti,, D. Bosisio,, M. K. Prahladan,, and A. Mantovani. 2000. Toll-like receptors: a growing family of immune receptors that are differentially expressed and regulated by different leukocytes. J. Leukoc. Biol. 67: 450– 456.

81. Naik, S.,, E. J. Kelly,, L. Meijer,, S. Pettersson,, and I. R. Sanderson. 2001. Absence of Toll-like receptor 4 explains endotoxin hyporesponsiveness in human intestinal epithelium. J. Pediatr. Gastroenterol. Nutr. 32: 449– 453.

82. Nathan, C.,, and A. Ding. 2001. TREM-1: A new regulator of innate immunity in sepsis syndrome. Nat. Med. 7: 530– 532.

83. Neish, A. S.,, A. T. Gewirtz,, H. Zeng,, A. N. Young,, M. E. Hobert,, V. Karmali,, A. S. Rao,, and J. L. Madara. 2000. Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquination. Science 289: 1560– 1563.

84. Ogura, Y.,, D. K. Bonen,, N. Inohara,, D. L. Nicolae,, F. F. Chen,, R. Ramos,, H. Britton,, T. Moran,, R. Karaliuskas,, R. H. Duerr,, J. P. Aklar,, S. R. Brant,, T. M. Bayless,, B. S. Kirschner,, S. B. Hanauer,, G. Nunez,, and J. H. Cho. 2001. A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature 411: 603– 608.

85. Ohashi, K.,, V. Burkart,, S. Flohe,, and H. Kolb. 2000. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the Toll-like receptor-4 complex. J. Immunol. 164: 558– 561.

86. Okamura, Y.,, M. Watari,, E. S. Jerud,, D. W. Young,, S. T. Ishizaka,, J. Rose,, J. C. Chow,, and J. F. Strauss 3rd. 2001. The extra domain A of fibronectin activates Toll-like receptor 4. J. Biol. Chem. 276: 10229– 10233.

87. O’Neill, L. 2000. The Toll/interleukin-1 receptor domain: a molecular switch for inflammation and host defence. Biochem. Soc. Trans. 28: 557– 563.

88. O’Neill, L. 2001. Specificity in the innate response: pathogen recognition by Toll-like receptor combinations. Trends Immunol. 22: 70.

89. Ozinsky, A.,, D. M. Underhill,, J. D. Fontenot,, A. M. Hajjar,, K. D. Smith,, C. B. Wilson,, L. Schroeder,, and A. Aderem. 2000. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors. Proc. Natl. Acad. Sci. USA 97: 13766– 13771.

90. Perera, P. Y.,, T. N. Mayadas,, O. Takeuchi,, S. Akira,, M. Zaks-Zilberman,, S. M. Goyert,, and S. N. Vogel. 2001. CD11b/CD18 acts in concert with CD14 and Toll-like receptor (TLR) 4 to elicit full lipopolysaccharide and taxolinducible gene expression. J. Immunol. 166: 574– 581.

91. Podolsky, D. K. 1999. Mucosal immunity and inflammation. V. Innate mechanisms of mucosal defense and repair: the best offense is a good defense. Am. J. Physiol. 277: G495– G499.

92. Podolsky, D. K. 2000. Review article: healing after inflammatory injury—coordination of a regulatory peptide network. Aliment. Pharmacol. Ther. 14: 87– 93.

93. Poltorak, A.,, P. Ricciardi-Castagnoli,, S. Citterio,, and B. Beutler. 2000. Physical contact between lipopolysaccharide and Toll-like receptor 4 revealed by genetic complementation. Proc. Natl. Acad. Sci. USA 97: 2163– 2167.

94. Pridmore, A. C.,, D. H. Wyllie,, F. Abdillahi,, L. Steeghs,, P. van der Ley,, S. K. Dower,, and R. C. Read. 2001. A lipopolysaccharide-deficient mutant of Neisseria meningitidis elicits attenuated cytokine release by human macrophages and signals via Toll-like receptor (TLR) 2 but not via TLR4/MD2. J. Infect. Dis. 183: 89– 96.

95. Pugin, J.,, C. C. Schurer-Maly,, D. Leturcq,, A. Moriarty,, R. J. Ulevitch,, and P. S. Tobias. 1993. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc. Natl. Acad. Sci. USA 90: 2744– 2748.

96. Qureshi, S. T.,, P. Gros,, and D. Malo. 1999. The Lps locus: genetic regulation of host responses to bacterial lipopolysaccharide. Inflamm. Res. 48: 613– 620.

97. Randow, F.,, and B. Seed. 2001. Endoplasmic reticulum chaperone gp96 is required for innate immunity but not cell viability. Nat. Cell Biol. 3: 891– 896.

98. Rehli, M.,, A. Poltorak,, L. Schwarzfischer,, S. W. Krause,, R. Andreesen,, and B. Beutler. 2000. PU.1 and interferon consensus sequence-binding protein regulate the myeloid expression of the human Toll-like receptor 4 gene. J. Biol. Chem. 275: 9773– 9781.

99. Rock, F. L.,, G. Hardiman,, J. C. Timans,, R. A. Kastelein,, and J. F. Bazan. 1998. A family of human receptors structurally related to Drosophila Toll. Proc. Natl. Acad. Sci. USA 95: 588– 593.

100. Sato, S.,, F. Nomura,, T. Kawai,, O. Takeuchi,, P. F. Muhlradt,, K. Takeda,, and S. Akira. 2000. Synergy and cross-tolerance between Toll-like receptor (TLR) 2-and TLR4-mediated signaling pathways. J. Immunol. 165: 7096– 7101.

101. Schumann, R. R. 1992. Function of lipopolysaccharide (LPS)-binding protein (LBP) and CD14, the receptor for LPS/LBP complexes: a short review. Res. Immunol. 143: 11– 15.

102. Seki, E.,, H. Tsutsui,, H. Nakano,, N. M. Tsuji,, K. Hoshino,, O. Adachi,, K. Adachi,, S. Futatsugi,, K. Kuida,, O. Takeuchi,, H. Okamura,, J. Fujimoto,, S. Akira,, and K. Nakanishi. 2001. Lipopolysaccharide-induced IL-18 secretion from murine Kupffer cells independently of MyD88 that is critically involved in induction of production of IL-12 and IL-1 β. J. Immunol. 166: 2651– 2657.

103. Seya, T.,, M. Matsumoto,, S. Tsuji,, N. A. Begum,, M. Nomura,, I. Azuma,, A. Hayashi,, and K. Toyoshima. 2001 . Two receptor theory in innate immune activation: studies on the receptors for bacillus Callmette-Guérin-cell wall skeleton. Arch. Immunol. Ther. Exp. (Warszawa) 49: S13– S21.

104. Seydel, K. B.,, E. Li,, P. E. Swanson, , and S. L. Stanley, Jr. 1997. Human intestinal epithelial cells produce proinflammatory cytokines in response to infection in a SCID mouse-human intestinal xenograft model of amebiasis. Infect. Immun. 65: 1631– 1639.

105. Shen, B.,, and J. L. Manley. 1998. Phosphorylation modulates direct interactions between the Toll receptor, Pelle kinase and Tube. Development 125: 4719– 4728.

106. Shuto, T.,, H. Xu,, B. Wang,, J. Han,, H. Kai,, X. X. Gu,, T. F. Murphy,, D. J. Lim,, and J. D. Li. 2001. Activation of NF-kappa B by nontypeable Hemophilus influenzae is mediated by Toll-like receptor 2-TAK1-dependent NIK-IKK alpha/beta-I kappa B alpha and MKK3/6-p38 MAP kinase signaling pathways in epithelial cells. Proc. Natl. Acad. Sci. USA 98: 8774– 8779.

107. Smith, P. D.,, E. N. Janoff,, M. Mosteller-Barnum,, M. Merger,, J. M. Orenstein,, J. F. Kearney,, and M. F. Graham. 1997. Isolation and purification of CD14-negative mucosal macrophages from normal human small intestine. J. Immunol. Methods 202: 1– 11.

108. Smith, P. D.,, L. E. Smythies,, M. Mosteller-Barnum,, D. A. Sibley,, M. W. Russell,, M. Merger,, M. T. Sellers,, J. M. Orenstein,, T. Shimada,, M. F. Graham,, and H. Kubagawa. 2001. Intestinal macrophages lack CD14 and CD89 and consequently are down-regulated for LPS-and IgA-mediated activities. J. Immunol. 167: 2651– 2656.

109. Staege, H.,, A. Schaffner,, and M. Schneemann. 2000. Human Toll-like receptors 2 and 4 are targets for deactivation of mononuclear phagocytes by interleukin-4. Immunol. Lett. 71: 1– 3.

110. Takeshita, F.,, C. A. Leifer,, I. Gursel,, K. J. Ishii,, S. Takeshita,, M. Gursel,, and D. M. Klinman. 2001. Cutting edge: role of Toll-like receptor 9 in CpG DNA-induced activation of human cells. J. Immunol. 167: 3555– 3558.

111. Takeuchi, O.,, K. Hoshino,, and S. Akira. 2000. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus Aureus infection. J. Immunol. 165: 5392– 5396.

112. Takeuchi, O.,, K. Hoshino,, T. Kawai,, H. Sanjo,, H. Takada,, T. Ogawa,, K. Takeda,, and S. Akira. 1999. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11: 443– 451.

113. Takeuchi, O.,, T. Kawai,, H. Sanjo,, N. G. Copeland,, D. J. Gilbert,, N. A. Jenkins,, K. Takeda,, and S. Akira. 1999. TLR6: a novel member of an expanding Toll-like receptor family. Gene 231: 59– 65.

114. Takeuchi, O.,, K. Takeda,, K. Hoshino,, O. Adachi,, T. Ogawa,, and S. Akira. 2000. Cellular responses to bacterial cell wall components are mediated through MyD88-dependent signaling cascades. Int. Immunol. 12: 113– 117.

115. Tapping, R. I.,, S. Akashi,, K. Miyake,, P. J. Godowski,, and P. S. Tobias. 2000. Toll-like receptor 4, but not Toll-like receptor 2, is a signaling receptor for Escherichia and Salmonella lipopolysaccharides. J. Immunol. 165: 5780– 5787.

116. Thoma-Uszynski, S.,, S. M. Kiertscher,, M. T. Ochoa,, D. A. Bouis,, M. V. Norgard,, K. Miyake,, P. J. Godowski,, M. D. Roth,, and R. L. Modlin. 2000. Activation of Toll-like receptor 2 on human dendritic cells triggers induction of IL-12, but not IL-10. J. Immunol. 165: 3804– 3810.

117. Uehara, A.,, S. Sugawara,, R. Tamai,, and H. Takada. 2001. Contrasting responses of human gingival and colonic epithelial cells to lipopolysaccharides, lipoteichoic acids and peptidoglycans in the presence of soluble CD14. Med. Microbiol. Immunol. (Berlin) 189: 185– 192.

118. Underhill, D. M.,, A. Ozinsky,, A. M. Hajjar,, A. Stevens,, C. B. Wilson,, M. Bassetti,, and A. Aderem. 1999. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 401: 811– 815.

119. Visintin, A.,, A. Mazzoni,, J. A. Spitzer,, and D. M. Segal. 2001. Secreted MD-2 is a large polymeric protein that efficiently confers lipopolysaccharide sensitivity to Toll-like receptor 4. Proc. Natl. Acad. Sci. USA 98: 12156– 12161.

120. Visintin, A.,, A. Mazzoni,, J. H. Spitzer,, D. H. Wyllie,, S. K. Dower,, and D. M. Segal. 2001. Regulation of Toll-like receptors in human monocytes and dendritic cells. J. Immunol. 166: 249– 255.

121. Vogel, S. N.,, D. Johnson,, P. Y. Perera,, A. Medvedev,, L. Lariviere,, S. T. Qureshi,, and D. Malo. 1999. Cutting edge: functional characterization of the effect of the C3H/HeJ defect in mice that lack an Lpsn gene: in vivo evidence for a dominant negative mutation. J. Immunol. 162: 5666– 5670.

122. Wang, Q.,, R. Dziarski,, C. J. Kirschning,, M. Muzio,, and D. Gupta. 2001. Micrococci and peptidoglycan activate TLR2→MyD88→ IRAK→TRAF→NIK→IKK→NF-kappaB signal transduction pathway that induces transcription of interleukin-8. Infect. Immun. 69: 2270– 2276.

123. Werts, C.,, R. I. Tapping,, J. C. Mathison,, T. H. Chuang,, V. Kravchenko,, I. Saint Girons,, D. A. Haake,, P. Godowski,, F. Hayashi,, A. Ozinsky,, D. M. Underhill,, C. J. Kirschning,, H. Wagner,, A. Aderem,, P. S. Tobias,, and R. J. Ulevitch. 2001. Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism. Nat. Immunol. 2: 346– 352.

124. Wesche, H.,, W. J. Henzel,, W. Shillinglaw,, S. Li,, and Z. Cao. 1997. MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity 7: 837– 847.

125. Witthoft, T.,, L. Eckmann,, J. M. Kim,, and M. F. Kagnoff. 1998. Enteroinvasive bacteria directly activate expression of iNOS and NO production in human colon epithelial cells. Am. J. Physiol. 275: G564– G571.

126. Xavier, R. J.,, and D. K. Podolsky. 2000. Microbiology. How to get along—friendly microbes in a hostile world [comment]. Science 289: 1483– 1484.

127. Xu, Y.,, X. Tao,, B. Shen,, T. Horng,, R. Medzhitov,, J. L. Manley,, and L. Tong. 2000. Structural basis for signal transduction by the Toll/interleukin-1 receptor domains. Nature 408: 111– 115.

128. Yang, S. K.,, L. Eckmann,, A. Panja,, and M. F. Kagnoff. 1997. Differential and regulated expression of C-X-C, C-C, and Cchemokines by human colon epithelial cells Gastroenterology 113: 1214– 1223.

129. Zhang, F. X.,, C. J. Kirschning,, R. Mancinelli,, X. P. Xu,, Y. Jin,, E. Faure,, A. Mantovani,, M. Rothe,, M. Muzio,, and M. Arditi. 1999. Bacterial lipopolysaccharide activates nuclear factor-kappaB through interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes. J. Biol. Chem. 274: 7611– 7614.